Chikungunya Vaccine Trial Shows PromiseChikungunya Vaccine Trial Shows Promise

A live recombinant vaccine against chikungunya infection, produced by modifying the measles vaccine virus, was safe and induced a good immune response in healthy volunteers in a new study from Austria. Reuters Health Information
Source: Medscape Infectious Diseases Headlines - Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news